Starpharma SPL7013 Nasal Spray for COVID-19 – Development Update
![Starpharma SPL7013 Nasal Spray for COVID19 Development Update](/thumb/phpThumb.php?src=%2Fuploads%2Fnews%2F13%2F1307%2F5%2F1307565-starpharma-spl7013-nasal-spray-for-covid-19-development-update.jpg&w=750&hash=0f4d789be4fc79f2106d8bfbd40fe138)
MELBOURNE, Australia--(BUSINESS WIRE)--Aug 25, 2020--. Starpharma (ASX: SPL, OTCQX: SPHRY) today announced progress with development, regulatory and manufacturing activities associated with a nasal spray for protection against COVID-19"...